David Windley
Stock Analyst at Jefferies
(3.55)
# 821
Out of 5,163 analysts
204
Total ratings
64.71%
Success rate
13.12%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $98.33 | +37.29% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $450.41 | +24.33% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $165.43 | +42.05% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $164.72 | +54.81% | 6 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $282.09 | +20.53% | 28 | Jan 28, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $77.37 | - | 1 | Dec 3, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $8.94 | +6.26% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $155.46 | +25.43% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $214.57 | +22.57% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $0.65 | +322.95% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $34.45 | +77.07% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $13.23 | -9.30% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $267.19 | +57.94% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $149.20 | +99.06% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.34 | +1,001.97% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $291.63 | +107.11% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $472.16 | -20.58% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $13.42 | +15.54% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $178.88 | +50.94% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $6.65 | +133.08% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $235.46 | +127.64% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $14.99 | +93.46% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.37 | +4,518.25% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.79 | - | 5 | Oct 9, 2017 |
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $98.33
Upside: +37.29%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $450.41
Upside: +24.33%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $165.43
Upside: +42.05%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $164.72
Upside: +54.81%
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $282.09
Upside: +20.53%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $77.37
Upside: -
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $8.94
Upside: +6.26%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $155.46
Upside: +25.43%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $214.57
Upside: +22.57%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.65
Upside: +322.95%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $34.45
Upside: +77.07%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.23
Upside: -9.30%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $267.19
Upside: +57.94%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $149.20
Upside: +99.06%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.34
Upside: +1,001.97%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $291.63
Upside: +107.11%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $472.16
Upside: -20.58%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $13.42
Upside: +15.54%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $178.88
Upside: +50.94%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $6.65
Upside: +133.08%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $235.46
Upside: +127.64%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $14.99
Upside: +93.46%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.37
Upside: +4,518.25%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.79
Upside: -